| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |